Prevention and management of chronic heart failure with electrical therapy

American Journal of Cardiology

Volumn 91, Issue 9 SUPPL. 1, 2003, Pages 62-73

  Engelstein, Erica D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALGORITHM; CARDIOMYOPATHY; CATHETER ABLATION; CAUSE OF DEATH; CHRONIC DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; HEART ASSIST DEVICE; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART PACING; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; SUDDEN DEATH; SURGICAL RISK; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0038742952     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03340-4     Document Type: Conference Paper

References (68)

1. Engelstein E.D., Zipes D.P. Sudden cardiac death. Alexander R.W., Schlant R.C., Fuster V. Hurst's The Heart. 9th ed: 1998;1081-1112 McGraw Hill, New York.
2. Effect of metoprolol CR/XL in chronic heart failure the Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) . Lancet. 353:1999;2001-2007.
3. Teerlink J.R., Jalaluddin M., Anderson S., Kukin M.L., Eichhorn E.J., Francis G., Packer M., Massie B.M. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation. 101:2000;40-46.
4. Singh S.N., Carson P.E., Fisher S.G. Nonsustained ventricular tachycardia in severe heart failure. Circulation. 96:1997;3794-3795.
5. Doval H.C., Nul D.R., Grancelli H.O., Varini S.D., Soifer S., Corrado G., Dubner S., Scapin O., Perrone S.V. Nonsustained ventricular tachycardia in severe heart failure independent marker of increased mortality due to sudden death . Circulation. 94:1996;3198-3203.
6. Bansch D., Bocker D., Brunn J., Weber M., Breithardt G., Block M. Clusters of ventricular tachycardia signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol. 36:2000;566-573.
7. Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation. 85:(suppl):1992;150-156.
8. Koilpillai C., Quinones M.A., Greenberg B., Limacher M.C., Shindler D., Pratt C.M., Benedict C.R., Kopelen H., Shelton B. Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction. Am J Cardiol. 77:1996;606-611.
9. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
10. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1992;293-302.
11. Doval H.C., Nul D.R., Grancelli H.O., Perrone S.V., Bortman G.R., Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 344:1994;493-498.
12. Effects of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) . N Engl J Med. 316:1987;1429-1435.
13. Peters K.G., Kienzle M.G. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation complete recovery after restoration of sinus rhythm . Am J Med. 85:1988;242-244.
14. Torp-Pedersen C., Moller M., Bloch-Thomsen P.E., Kober L., Sandoe E., Egstrup K., Agner E., Carlsen J., Videbaek J., Marchant B., Camm A.J. Dofetilide in patients with congestive heart failure and left ventricular dysfunction Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group . N Engl J Med. 341:1999;857-865.
15. Mathew J., Hunsberger S., Fleg J., McSherry F., Williford W., Yusuf S. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest. 118:2000;914-922.
16. Stein K.M., Euler D.E., Mehra R., Seidl K., Slotweiner D.J., Mittal S., Markowitz S.M., Lerman B.B. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients? J Am Coll Cardiol. 40:2002;335-340.
17. Buxton A.E., Lee K.L., DiCarlo L., Gold M.R., Greer G.S., Prystowsky E.N., O'Toole M.F., Tang A., Fisher J.D., Coromilas J., Talajic M., Hafley G. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med. 342:2000;1937-1945.
18. Chen X., Shenasa M., Borggrefe M., Block M., Hindricks G., Martinez-Rubio A., Haverkamp S., Willems D., Bocker D., Makijarvi M., Breithardt G. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias inducibility and prognostic value in 102 patients . Eur Heart J. 15:1994;76-82.
19. Turitto G., Ahuja R.K., Caref E.B., El-Sharif N. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia role of programmed ventricular stimulation and the signal-average electrocardiogram . J Am Coll Cardiol. 24:1994;1523-1528.
20. Pogwizd S.M., McKenzie J.P., Cain M.E. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation. 98:1998;2404-2414.
21. Roden D.M. Risks and benefits of antiarrhythmic therapy. N Engl J Med. 331:1994;785-791.
22. Pappone C, Vicedomini G, Augello G, Mazzone P, Nardi S, Rosanio S. Combining electrical therapies for advanced heart failure: the Milan experience with biventricular pacing-defibrillation backup combination for primary prevention of sudden cardiac death. Am J Cardiol 2003;(suppl):74F-80F.
23. Zipes D.P., Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator a comparison of epicardial and endocardial lead systems . Circulation. 92:1995;59-62.
24. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias the Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators . N Engl J Med. 337:1997;1576-1583.
25. Kuck K., Cappato R., Siebels J., Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest the Cardiac Arrest Study Hamburg (CASH) . Circulation. 102:2000;748-754.
26. Connolly S.J., Gent M., Roberts R.S., Dorian P., Roy D., Sheldon R.S., Mitchell L.B., Green M.S., Klein G.J., O'Brien B. Canadian Implantable Defibrillator Study (CIDS) a randomized trial of the implantable cardioverter defibrillator against amiodarone . Circulation. 101:2000;1297-1302.
27. Connolly S.J., Hallstrom A.P., Cappato R., Schron E.B., Kuck K.H., Zipes D.P., Greene H.L., Boczor S., Domanski M., Follmann D., Gent M., Roberts R.S. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J. 21:2000;2071-2078.
28. Ehlert F.A., Cannom D.S., Rebfroe E.G., Greene H.L., Ledingham R., Mitchell L.B., Anderson J.L., Halperin B.D., Herre J.M., Luceri R.M., Marinchak R.A., Steinberg J.S. Comparison of dilated cardiomyopathy and coronary artery disease in patients with life-threatening ventricular arrhythmias differences in presentation and outcome in the AVID registry . Am Heart J. 142:2001;816-822.
29. Cappato R. Secondary prevention of sudden death the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study . Am J Cardiol. 83:(suppl):1999;68D-73D.
30. Domanski M.J., Sakseena S., Epstein A.E., Hallstrom A.P., Brodsky M.A., Kim S., Lancaster S., Schron E. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol. 34:1999;1090-1095.
31. Moss A.J., Hall W.J., Cannom D.S., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M. Improved survival with an implantable defibrillator in patients with coronary artery disease at high risk of ventricular arrhythmia. N Engl J Med. 335:1996;1933-1940.
32. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., Hafley G. A randomized study of prevention of sudden death in patients with coronary artery disease Multicenter Unsustained Tachycardia Trial Investigators . N Engl J Med. 341:1999;1882-1890.
33. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., Andrews M.L. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 346:2002;877-883.
34. Bigger J.T. Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery Coronary Artery Bypass Graft (CABG) Patch Trial Investigators . N Engl J Med. 337:1997;1569-1575.
35. Strickberger AS. Amiodarone versus implantable defibrillators in patients with nonischemic cardiomyopathy and asymptomatic nonsustained ventricular tachycardia. Late-breaking clinical trials. Presented at: American College of Cardiology 51st Annual Scientific Sessions; March 19, 2002; Atlanta, Georgia.
36. Bansch D., Antz M., Boczor S., Volkmer M., Tebbenjohanns J., Seidl K., Block M., Gietzen F., Berger J., Kuck K.H. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy the Cardiomyopathy Trial (CAT) . Circulation. 105:2002;1453-1458.
37. McMurray J., Pfeffer M.A. New therapeutic options in congestive heart failure I . Circulation. 105:2002;2099-2106.
38. Middlekauf H.R., Stevenson W.G., Stevenson L.W., Saxon L.A. Syncope in advanced heart failure high risk of sudden death regardless of origin of syncope . J Am Coll Cardiol. 21:1993;110-116.
39. Fonarow G.C., Feliciano Z., Boyle N., Knight L., Woo M., Moriguchi J., Laks H., Wiener I. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable defibrillator. Am J Cardiol. 85:2000;981-985.
40. Sweeney M.O., Ruskin J.N., Garan H., McGovern B.A., Guy M.L., Torchiana D.F., Vlahakes G.J., Newell J.B., Semigran M.J., Dec G.W. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation. 92:1995;3273-3281.
41. Sandner S.E., Wieselthaler G., Zuckermann A., Taghavi S., Schmidinger H., Pacher R., Ploner M., Laufer G., Wolner E., Grimm M. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation. 104:(suppl 1):2001;I-171-I-176.
42. Bilchick K.C., Fetics B., Djoukeng R., Fisher S.G., Fletcher R.D., Singh S.N., Nevo E., Berger R.D. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol. 90:2002;24-28.
43. Berger R., Huelsman M., Strecker K., Bojic A., Moser P., Stanek B., Pacher R. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 105:2002;2392-2397.
44. Rothman S.A., Hsia H.H., Cossu S.F., Chanielewski I.L., Buxton A.E., Miller J.M. Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias. Circulation. 96:1997;3499-3508.
45. Stevenson W.G., Friedman P.L., Kocovic D., Sager P.T., Saxon L.A., Pavri B. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation. 98:1998;308-314.
46. Stevenson W.G. Catheter mapping of ventricular tachycardia. Zipes D.P., Jalifé J. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed: 1995;1093-1112 WB Saunders, Philadelphia.
47. Calkins H., Epstein A., Packer D., Arria A.M., Hummel J., Gilligan D.M., Trusso J., Carlson M., Luceri R., Kopelman H. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy. J Am Coll Cardiol. 35:2000;1905-1914.
48. Marchlinski F.E., Callans D.J., Gottlieb C.D., Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 101:2000;1288-1296.
49. Kottkamp H., Hindricks G., Chen X., Brunn J., Willems S., Haverkamp W., Block M., Breithardt G., Borggrefe M. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy. Circulation. 92:1995;1159-1168.
50. Raitt M.H., Klein R.C., Greene H.L., Wilkoff B.L., Wyse D.G., Beckman K.J., Martins J.B., Kim S.G., Epstein A.E., Engelstein E.D., Friedman P.L. Arrhythmia recurrence in patients presenting with ventricular fibrillation compared to ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. [abstract] Circulation. 98:1998;I-494.
51. Mureddu R., Bottoni N., Lolli G. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation a randomized, controlled study . Circulation. 98:1998;953-960.
52. Ozcan C., Jahangir A., Friedman P.A., Patel P.J., Munger T.M., Rea R.F., Lloyd M.A., Packer D.L., Hodge D.O., Gersh B.J., Hammill S.C., Shen W.K. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med. 344:2001;1043-1051.
53. Oral H., Knight B.P., Tada H., Ozaydin M., Chugh A., Hassan S., Scharf C., Lai S.W., Greenstein R., Pelosi F. Jr, Strickberger S.A., Morady F. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 105:2002;1077-1081.
54. Pappone C., Rosanio S., Oreto G., Tocchi M., Gugliotta F., Vicedomini G., Salvati A., Dicandia C., Mazzone P., Santinelli V., Gulletta S., Chierchia S. Circumferential radiofrequency ablation of pulmonary vein ostia a new anatomic approach for curing atrial fibrillation . Circulation. 102:2000;2619-2628.
55. Haissaguerre M., Jais P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A., Le Metayer P., Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 339:1998;659-666.
56. Varma C., Camm A.J. Pacing for heart failure. Lancet. 357:2001;1277-1283.
57. Lamas G.A., Lee K.L., Sweeney M.O., Silverman R., Leon A., Yee R., Marinchak R.A., Flaker G., Schron E., Orav E.J., Hellkamp A.S., Goldman L. for the Mode Selection Trial in Sinus Node Dysfunction. Ventricular pacing or dual chamber pacing for sinus node dysfunction. N Engl J Med. 346:2002;1854-1862.
58. Cooper J.M., Katcher M.S., Orlov M.V. Implantable devices for the treatment of atrial fibrillation. N Engl J Med. 346:2002;2062-2068.
59. Shinbane J.S., Chu E., DeMarco T., Sobol Y., Fitzpatrick A.P., Lau D.M., Klinski C., Schiller N.B., Griffin J.C., Chatterjee K. Evaluation of dual chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure. J Am Coll Cardiol. 30:1997;1295-1300.
60. Linde C., Gadler F., Edner M., Nordlander R., Rosenqvist M., Ryden L. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol. 75:1995;919-923.
61. Nishimura R.A., Hayes D.L., Holmes D.R., Tajik J.A. Mechanism of hemodynamic improvement by dual chamber pacing for severe left ventricular dysfunction an acute Doppler and catheterization study . J Am Coll Cardiol. 25:1995;281-288.
62. Nielsen J.C., Andersen H.R., Thomsen P.E., Thuesen L., Mortensen P.T., Vesterlund T., Pedersen A.K. Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. Circulation. 97:1998;987-995.
63. Saxon L.A., Stevenson W.G., Middlekauff H.R., Stevenson L.W. Increased risk of progressive deterioration in advanced heart failure patients requiring permanent pacemakers. Am Heart J. 125:1993;1306-1309.
64. Deshmukh P., Casavant D.A., Romanyshyn M., Anderson K. Permanent, direct His-bundle pacing a novel approach to cardiac pacing in patients with normal His-Purkinje activation . Circulation. 101:2000;869-877.
65. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Packer M., Clavell A.L., Hayes D.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 346:2002;1845-1853.
66. Ansalone G, Giannantoni P, Ricci R, Trambaiolo P, Fedele F, Santini M. Biventricular pacing in heart failure: back to basics in the pathophysiology of left bundle branch block to reduce the number of nonresponders. Am J Cardiol 2003;(suppl):55F-61F.
67. Hayes D.L., Zipes D.P. Implantable cardioverter defibrillation therapy. Braunwald E., Zipes D.P., Libby P. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed: 2001;801-810 WB Saunders, Philadelphia.
68. Wyse DG. Atrial Fibrillation Follow-up Investigation in Rhythm Management (AFFIRM). Presented at: American College of Cardiology 51st Annual Scientific Sessions; March 19, 2002; Atlanta, Georgia.